Latest filingAug 20, 2026Most recent Form 4
SKYE
Skye Bioscience, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$28.0M18 sells
Net open-market-$28.0M9 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period18transactions
- S · Open-market sells · dominant18 · 100%
Activity by reported role
A joint filing can contribute to multiple roles18transactions
- 10% owner · dominant9 · 50%
- Director9 · 50%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (9)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeRocklage Scott MCommon Stock · Indirect · By 5AM Ventures VII, L.P.
7,850,155Aug 20, 2026
Rocklage Scott MCommon Stock · Indirect · By 5AM Ventures II, L.P.
1,400,560Aug 20, 2026
Rocklage Scott MCommon Stock · Indirect · By 5AM Co-Investors II, L.P.
55,208Aug 20, 2026
Diekman John DCommon Stock · Indirect · By 5AM Ventures VII, L.P.
7,850,155Aug 20, 2026
Diekman John DCommon Stock · Indirect · By 5AM Co-Investors II, L.P.
55,208Aug 20, 2026
Diekman John DCommon Stock · Indirect · By 5AM Ventures II, L.P.
1,400,560Aug 20, 2026
5am Ventures Ii LpCommon Stock · Indirect · By 5AM Ventures VII, L.P.
7,850,155Aug 20, 2026
5am Ventures Ii LpCommon Stock · Indirect · By 5AM Co-Investors II, L.P.
55,208Aug 20, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- SJ-$140.3k
- 5L-$140.3k
Recent filing activity
Most recent 12 transactions · color = transaction codeFiling detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
SKYE transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| SKYE | Schwab Andrew J. | DIR | sale | 6.49k | -$207k | S | +542.9% | 08/20 | 08/20 | |
| SKYE | Schwab Andrew J. | DIR | sale | 46 | -$1.47k | S | +542.9% | 08/20 | 08/20 | |
| SKYE | Schwab Andrew J. | DIR | sale | 1.15k | -$37.0k | S | +542.9% | 08/20 | 08/20 | |
| SKYE | Schwab Andrew J. | DIR | sale | 57.4k | -$2.01M | S | +542.9% | 08/20 | 08/19 | |
| SKYE | Schwab Andrew J. | DIR | sale | 409 | -$14.3k | S | +542.9% | 08/20 | 08/19 | |
| SKYE | Schwab Andrew J. | DIR | sale | 10.2k | -$358k | S | +542.9% | 08/20 | 08/19 | |
| SKYE | Schwab Andrew J. | DIR | sale | 253k | -$9.61M | S | +542.9% | 08/20 | 08/18 | |
| SKYE | Schwab Andrew J. | DIR | sale | 1.83k | -$69.5k | S | +542.9% | 08/20 | 08/18 | |
| SKYE | Schwab Andrew J. | DIR | sale | 45.0k | -$1.71M | S | +542.9% | 08/20 | 08/18 | |
| SKYE | 5AM Partners VII, LLC | 10% | sale | 6.49k | -$207k | S | +542.9% | 08/20 | 08/20 | |
| SKYE | 5AM Partners VII, LLC | 10% | sale | 46 | -$1.47k | S | +542.9% | 08/20 | 08/20 | |
| SKYE | 5AM Partners VII, LLC | 10% | sale | 1.15k | -$37.0k | S | +542.9% | 08/20 | 08/20 | |
| SKYE | 5AM Partners VII, LLC | 10% | sale | 57.4k | -$2.01M | S | +542.9% | 08/20 | 08/19 | |
| SKYE | 5AM Partners VII, LLC | 10% | sale | 409 | -$14.3k | S | +542.9% | 08/20 | 08/19 | |
| SKYE | 5AM Partners VII, LLC | 10% | sale | 10.2k | -$358k | S | +542.9% | 08/20 | 08/19 | |
| SKYE | 5AM Partners VII, LLC | 10% | sale | 253k | -$9.61M | S | +542.9% | 08/20 | 08/18 | |
| SKYE | 5AM Partners VII, LLC | 10% | sale | 1.83k | -$69.5k | S | — | +542.9% | 08/20 | 08/18 |
| SKYE | 5AM Partners VII, LLC | 10% | sale | 45.0k | -$1.71M | S | — | +542.9% | 08/20 | 08/18 |
Skye Bioscience, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Skye Bioscience, Inc.?
Schwab Andrew J., 5AM CO-INVESTORS II LP, 5AM Partners II, LLC, 5AM Partners VII, LLC, 5AM Ventures II LP, 5AM Ventures VII, L.P., DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Schwab Andrew J. reported a sale on Aug 20, 2026 valued at $207k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $280,626.00. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.